

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.86597988 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.61851964 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.40956152 |
| 4 | GDP-mannose metabolic process (GO:0019673) | 5.32745935 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.32289327 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.19587245 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.14474410 |
| 8 | glutamate secretion (GO:0014047) | 4.96373033 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.85920560 |
| 10 | mannose metabolic process (GO:0006013) | 4.82122106 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.73028325 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.61545533 |
| 13 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.44236108 |
| 14 | vocalization behavior (GO:0071625) | 4.39311198 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.38205839 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.24393196 |
| 17 | sodium ion export (GO:0071436) | 4.17782354 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.07012099 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.03524822 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.95776433 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93476277 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.88637642 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.88119216 |
| 24 | activation of protein kinase A activity (GO:0034199) | 3.86996800 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.86847739 |
| 26 | proline transport (GO:0015824) | 3.86681840 |
| 27 | cellular potassium ion homeostasis (GO:0030007) | 3.86158833 |
| 28 | exploration behavior (GO:0035640) | 3.84791027 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.78307880 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.77585996 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.77585996 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 3.75535145 |
| 33 | regulation of synapse structural plasticity (GO:0051823) | 3.75292373 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.74120542 |
| 35 | cell communication by electrical coupling (GO:0010644) | 3.66490057 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.51918786 |
| 37 | protein localization to synapse (GO:0035418) | 3.50555009 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.46293037 |
| 39 | viral protein processing (GO:0019082) | 3.41776092 |
| 40 | UV protection (GO:0009650) | 3.35916248 |
| 41 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34866963 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33932638 |
| 43 | neuromuscular process controlling posture (GO:0050884) | 3.32417488 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.30655318 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27365527 |
| 46 | neurotransmitter transport (GO:0006836) | 3.26271712 |
| 47 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23482503 |
| 48 | cerebellar Purkinje cell layer development (GO:0021680) | 3.23428143 |
| 49 | regulation of vesicle fusion (GO:0031338) | 3.21522169 |
| 50 | virion assembly (GO:0019068) | 3.20117284 |
| 51 | metallo-sulfur cluster assembly (GO:0031163) | 3.19878122 |
| 52 | iron-sulfur cluster assembly (GO:0016226) | 3.19878122 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 3.18727854 |
| 54 | regulation of defense response to virus by virus (GO:0050690) | 3.18100041 |
| 55 | nuclear envelope reassembly (GO:0031468) | 3.17348828 |
| 56 | mitotic nuclear envelope reassembly (GO:0007084) | 3.17348828 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.17075818 |
| 58 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15372836 |
| 59 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.13290163 |
| 60 | glycine transport (GO:0015816) | 3.11998045 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.10540075 |
| 62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06124723 |
| 63 | alanine transport (GO:0032328) | 3.02157488 |
| 64 | proline biosynthetic process (GO:0006561) | 3.01743065 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01563339 |
| 66 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.01185451 |
| 67 | negative regulation of cell size (GO:0045792) | 2.99784897 |
| 68 | cell migration in hindbrain (GO:0021535) | 2.99471033 |
| 69 | long-term memory (GO:0007616) | 2.99311666 |
| 70 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97722736 |
| 71 | glutamate receptor signaling pathway (GO:0007215) | 2.97707752 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 2.96544185 |
| 73 | positive regulation of synapse maturation (GO:0090129) | 2.95068683 |
| 74 | positive regulation of membrane potential (GO:0045838) | 2.92809695 |
| 75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.92007127 |
| 76 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.91535915 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 2.91488131 |
| 78 | amino sugar catabolic process (GO:0046348) | 2.90848475 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 2.90179411 |
| 80 | modulation by virus of host process (GO:0019054) | 2.88582980 |
| 81 | ribosomal small subunit biogenesis (GO:0042274) | 2.88389766 |
| 82 | potassium ion import (GO:0010107) | 2.86059187 |
| 83 | dendritic spine morphogenesis (GO:0060997) | 2.86024569 |
| 84 | cellular sodium ion homeostasis (GO:0006883) | 2.84325794 |
| 85 | regulation of postsynaptic membrane potential (GO:0060078) | 2.83272755 |
| 86 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.83149640 |
| 87 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.83149640 |
| 88 | synaptic vesicle endocytosis (GO:0048488) | 2.82783110 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.81090736 |
| 90 | response to misfolded protein (GO:0051788) | 2.79060149 |
| 91 | base-excision repair, AP site formation (GO:0006285) | 2.79015048 |
| 92 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.78762732 |
| 93 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78717128 |
| 94 | protein retention in ER lumen (GO:0006621) | 2.76206189 |
| 95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.75640501 |
| 96 | protein insertion into membrane (GO:0051205) | 2.74723558 |
| 97 | regulation of beta-amyloid formation (GO:1902003) | 2.74218149 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.73367127 |
| 99 | membrane depolarization during action potential (GO:0086010) | 2.71971499 |
| 100 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.71805149 |
| 101 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.71342537 |
| 102 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70754715 |
| 103 | regulation of neurotransmitter transport (GO:0051588) | 2.69102712 |
| 104 | negative regulation of B cell apoptotic process (GO:0002903) | 2.68341552 |
| 105 | prepulse inhibition (GO:0060134) | 2.68272188 |
| 106 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.67957254 |
| 107 | viral transcription (GO:0019083) | 2.67260022 |
| 108 | cell communication involved in cardiac conduction (GO:0086065) | 2.65781075 |
| 109 | membrane repolarization (GO:0086009) | 2.65627729 |
| 110 | mating behavior (GO:0007617) | 2.65388560 |
| 111 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65152374 |
| 112 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.64362439 |
| 113 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.63410626 |
| 114 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.63287618 |
| 115 | activation of MAPKKK activity (GO:0000185) | 2.61644819 |
| 116 | positive regulation of protein dephosphorylation (GO:0035307) | 2.60137930 |
| 117 | potassium ion homeostasis (GO:0055075) | 2.59418483 |
| 118 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57820939 |
| 119 | positive regulation of protein homooligomerization (GO:0032464) | 2.57560238 |
| 120 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.57077624 |
| 121 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.56684657 |
| 122 | pentose-phosphate shunt (GO:0006098) | 2.56666583 |
| 123 | phagosome maturation (GO:0090382) | 2.56381387 |
| 124 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.56357266 |
| 125 | thymic T cell selection (GO:0045061) | 2.56275384 |
| 126 | negative regulation of microtubule polymerization (GO:0031115) | 2.54851036 |
| 127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54176932 |
| 128 | transferrin transport (GO:0033572) | 2.53838435 |
| 129 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.53226540 |
| 130 | vesicle transport along microtubule (GO:0047496) | 2.52924077 |
| 131 | axon cargo transport (GO:0008088) | 2.52606994 |
| 132 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.52013739 |
| 133 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.50944333 |
| 134 | response to acidic pH (GO:0010447) | 2.50908592 |
| 135 | intraspecies interaction between organisms (GO:0051703) | 2.50874136 |
| 136 | social behavior (GO:0035176) | 2.50874136 |
| 137 | regulation of ARF GTPase activity (GO:0032312) | 2.50733428 |
| 138 | neuromuscular process (GO:0050905) | 2.50716499 |
| 139 | membrane depolarization (GO:0051899) | 2.50263905 |
| 140 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.49839984 |
| 141 | amyloid precursor protein catabolic process (GO:0042987) | 2.49635491 |
| 142 | modulation by symbiont of host cellular process (GO:0044068) | 2.48473285 |
| 143 | neuronal ion channel clustering (GO:0045161) | 2.48390376 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.48337754 |
| 145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.48026176 |
| 146 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47780910 |
| 147 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.47458946 |
| 148 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47455232 |
| 149 | dendrite morphogenesis (GO:0048813) | 2.47350953 |
| 150 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.46290455 |
| 151 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.46182090 |
| 152 | innervation (GO:0060384) | 2.45780757 |
| 153 | regulation of synaptic transmission (GO:0050804) | 2.45541440 |
| 154 | glucose 6-phosphate metabolic process (GO:0051156) | 2.44448855 |
| 155 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43686783 |
| 156 | positive regulation of neurotransmitter transport (GO:0051590) | 2.43159735 |
| 157 | suckling behavior (GO:0001967) | 2.43021063 |
| 158 | glucose catabolic process (GO:0006007) | 2.42926662 |
| 159 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.42005428 |
| 160 | regulation of mitochondrial membrane potential (GO:0051881) | 2.41694975 |
| 161 | signal release (GO:0023061) | 2.41435914 |
| 162 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.41411094 |
| 163 | adhesion of symbiont to host (GO:0044406) | 2.40922659 |
| 164 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.40639954 |
| 165 | negative regulation of cell killing (GO:0031342) | 2.40639954 |
| 166 | autophagic vacuole fusion (GO:0000046) | 2.39982334 |
| 167 | opioid receptor signaling pathway (GO:0038003) | 2.39814750 |
| 168 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.38916480 |
| 169 | positive regulation of synaptic transmission (GO:0050806) | 2.38887094 |
| 170 | barbed-end actin filament capping (GO:0051016) | 2.38837877 |
| 171 | positive regulation of fibroblast migration (GO:0010763) | 2.38769339 |
| 172 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.35271755 |
| 173 | positive regulation of T cell apoptotic process (GO:0070234) | 2.33528212 |
| 174 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.33473650 |
| 175 | maintenance of protein localization in organelle (GO:0072595) | 2.33328620 |
| 176 | translational elongation (GO:0006414) | 2.31768429 |
| 177 | regulation of autophagic vacuole assembly (GO:2000785) | 2.31646966 |
| 178 | deoxyribonucleotide catabolic process (GO:0009264) | 2.30216863 |
| 179 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.28372959 |
| 180 | modulation by virus of host morphology or physiology (GO:0019048) | 2.28333492 |
| 181 | retrograde transport, endosome to Golgi (GO:0042147) | 2.27628514 |
| 182 | T cell apoptotic process (GO:0070231) | 2.27367008 |
| 183 | positive regulation of mitochondrion organization (GO:0010822) | 2.26163546 |
| 184 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.25138407 |
| 185 | positive regulation of TOR signaling (GO:0032008) | 2.24491423 |
| 186 | regulation of superoxide anion generation (GO:0032928) | 2.24387423 |
| 187 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.24182265 |
| 188 | negative regulation of interleukin-2 production (GO:0032703) | 2.23534431 |
| 189 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.22089558 |
| 190 | virion attachment to host cell (GO:0019062) | 2.21661782 |
| 191 | adhesion of symbiont to host cell (GO:0044650) | 2.21661782 |
| 192 | apoptotic process involved in morphogenesis (GO:0060561) | 2.21579270 |
| 193 | ferric iron transport (GO:0015682) | 2.20678359 |
| 194 | trivalent inorganic cation transport (GO:0072512) | 2.20678359 |
| 195 | positive regulation of nuclease activity (GO:0032075) | 2.20638346 |
| 196 | negative regulation of innate immune response (GO:0045824) | 2.20009828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.07534550 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92036241 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.86626964 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.74497583 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.69814554 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68040463 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54667087 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.48024364 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44326597 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44326597 |
| 11 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.44238696 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42933808 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41935648 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.39891609 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39092564 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38468202 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36257710 |
| 18 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.36203545 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31694910 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27505449 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.24775601 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17023934 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16613888 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.15692112 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15300718 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11894453 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10129038 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.07738446 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07655145 |
| 30 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07013017 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.05189538 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.03889942 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.99430672 |
| 34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96383483 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94099610 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.89105075 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87171689 |
| 38 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.82977719 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81829722 |
| 40 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.80447927 |
| 41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79351659 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.77761781 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76835366 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73675501 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71995982 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70281407 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69798349 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68591570 |
| 49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.67493050 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62384293 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61953169 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.61646033 |
| 53 | * MAF_26560356_Chip-Seq_TH2_Human | 1.60388267 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55128477 |
| 55 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54353303 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50520018 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49803561 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.49482879 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46672489 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46085984 |
| 61 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.45759634 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45339449 |
| 63 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.45223699 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.45007014 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42925605 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40815228 |
| 67 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40516225 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40445000 |
| 69 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.39577610 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38872271 |
| 71 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.37815913 |
| 72 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.37396745 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36869743 |
| 74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.36607575 |
| 75 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35492835 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34830399 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33857244 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33854042 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33328824 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33209612 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32881686 |
| 82 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29915077 |
| 83 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.29168815 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.28385095 |
| 85 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28248684 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27041133 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26751380 |
| 88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26521381 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25704717 |
| 90 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.24867099 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.24628619 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24599581 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23847804 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22729949 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21196590 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21049344 |
| 97 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20732040 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.19816178 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19657739 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.19389377 |
| 101 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18340797 |
| 102 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18252025 |
| 103 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18025452 |
| 104 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17554441 |
| 105 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17251311 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17181949 |
| 107 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15607941 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14747033 |
| 109 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.13736861 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.13677068 |
| 111 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.13627321 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 1.11749256 |
| 113 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11399997 |
| 114 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10875050 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.10653126 |
| 116 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.09943497 |
| 117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09938051 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07571827 |
| 119 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06825032 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.06743198 |
| 121 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05904124 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.05713891 |
| 123 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.05651311 |
| 124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05595588 |
| 125 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05494492 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04968981 |
| 127 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.03977939 |
| 128 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03943235 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03597657 |
| 130 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03541294 |
| 131 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.03360569 |
| 132 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03282729 |
| 133 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.99847548 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96687756 |
| 135 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96638203 |
| 136 | AR_19668381_ChIP-Seq_PC3_Human | 0.96623423 |
| 137 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96248451 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96240558 |
| 139 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95045993 |
| 140 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94817749 |
| 141 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.93921736 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92800303 |
| 143 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92654804 |
| 144 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92650481 |
| 145 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91615059 |
| 146 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91013610 |
| 147 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90984318 |
| 148 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90711660 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89143493 |
| 150 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88988467 |
| 151 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88836904 |
| 152 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88357465 |
| 153 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88008902 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86251890 |
| 155 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85838917 |
| 156 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.84741814 |
| 157 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84277345 |
| 158 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83877691 |
| 159 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83352878 |
| 160 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.82901510 |
| 161 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82565037 |
| 162 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81137869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.53315240 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.87993975 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.78887805 |
| 4 | MP0003880_abnormal_central_pattern | 3.17735526 |
| 5 | MP0003436_decreased_susceptibility_to | 3.15851125 |
| 6 | MP0004270_analgesia | 3.12266864 |
| 7 | MP0002064_seizures | 2.97060305 |
| 8 | MP0009745_abnormal_behavioral_response | 2.92011884 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.82230587 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.75219154 |
| 11 | MP0004858_abnormal_nervous_system | 2.66557932 |
| 12 | MP0002822_catalepsy | 2.64483387 |
| 13 | MP0008260_abnormal_autophagy | 2.57773940 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.54414865 |
| 15 | MP0003329_amyloid_beta_deposits | 2.48680560 |
| 16 | MP0009046_muscle_twitch | 2.46281076 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.30709272 |
| 18 | MP0002736_abnormal_nociception_after | 2.22471916 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.17843620 |
| 20 | MP0002272_abnormal_nervous_system | 2.13510165 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.13358986 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.12695882 |
| 23 | MP0009278_abnormal_bone_marrow | 2.09975028 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.07715002 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.00021409 |
| 26 | MP0000685_abnormal_immune_system | 1.99876091 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.99061836 |
| 28 | MP0001970_abnormal_pain_threshold | 1.96897560 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.96067748 |
| 30 | MP0003123_paternal_imprinting | 1.90687889 |
| 31 | MP0005451_abnormal_body_composition | 1.89534347 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.88701892 |
| 33 | MP0001486_abnormal_startle_reflex | 1.84816349 |
| 34 | MP0006082_CNS_inflammation | 1.84678994 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.80586825 |
| 36 | MP0008569_lethality_at_weaning | 1.74218867 |
| 37 | MP0005025_abnormal_response_to | 1.74215238 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.73330816 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.68293963 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.65790636 |
| 41 | MP0005387_immune_system_phenotype | 1.63560296 |
| 42 | MP0001790_abnormal_immune_system | 1.63560296 |
| 43 | MP0000751_myopathy | 1.63067844 |
| 44 | MP0003303_peritoneal_inflammation | 1.62995751 |
| 45 | MP0005671_abnormal_response_to | 1.57857061 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.56927754 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.56514257 |
| 48 | MP0003879_abnormal_hair_cell | 1.54672214 |
| 49 | MP0003075_altered_response_to | 1.53085890 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.51811500 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.49953622 |
| 52 | MP0000604_amyloidosis | 1.49751051 |
| 53 | MP0002419_abnormal_innate_immunity | 1.49013261 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.43992341 |
| 55 | MP0005083_abnormal_biliary_tract | 1.43274806 |
| 56 | MP0004130_abnormal_muscle_cell | 1.43228111 |
| 57 | MP0003633_abnormal_nervous_system | 1.41640543 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.40975437 |
| 59 | MP0003283_abnormal_digestive_organ | 1.40776354 |
| 60 | MP0000955_abnormal_spinal_cord | 1.39696573 |
| 61 | MP0002723_abnormal_immune_serum | 1.39408999 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.36746465 |
| 63 | MP0004043_abnormal_pH_regulation | 1.35409708 |
| 64 | MP0002184_abnormal_innervation | 1.35290256 |
| 65 | MP0001819_abnormal_immune_cell | 1.34402208 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.33557566 |
| 67 | MP0004924_abnormal_behavior | 1.33557566 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.32790826 |
| 69 | MP0002837_dystrophic_cardiac_calcinosis | 1.32233912 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.30188892 |
| 71 | MP0000681_abnormal_thyroid_gland | 1.28254946 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.27154240 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.27053391 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 1.26816060 |
| 75 | MP0000920_abnormal_myelination | 1.26038230 |
| 76 | MP0005360_urolithiasis | 1.25720533 |
| 77 | MP0000343_altered_response_to | 1.24921232 |
| 78 | MP0008874_decreased_physiological_sensi | 1.23541773 |
| 79 | MP0005535_abnormal_body_temperature | 1.23194128 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.23184059 |
| 81 | MP0001873_stomach_inflammation | 1.20902679 |
| 82 | MP0004510_myositis | 1.20892598 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.18997962 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.18371418 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.18107346 |
| 86 | MP0005464_abnormal_platelet_physiology | 1.17149157 |
| 87 | MP0002653_abnormal_ependyma_morphology | 1.15779368 |
| 88 | MP0001835_abnormal_antigen_presentation | 1.13795339 |
| 89 | MP0001800_abnormal_humoral_immune | 1.12961591 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 1.11703565 |
| 91 | MP0000858_altered_metastatic_potential | 1.11592434 |
| 92 | MP0006276_abnormal_autonomic_nervous | 1.11281394 |
| 93 | MP0002882_abnormal_neuron_morphology | 1.11121856 |
| 94 | MP0001905_abnormal_dopamine_level | 1.11107493 |
| 95 | MP0009785_altered_susceptibility_to | 1.11078016 |
| 96 | MP0001849_ear_inflammation | 1.10707274 |
| 97 | MP0008469_abnormal_protein_level | 1.07622537 |
| 98 | MP0000716_abnormal_immune_system | 1.06380513 |
| 99 | MP0003300_gastrointestinal_ulcer | 1.05698556 |
| 100 | MP0003631_nervous_system_phenotype | 1.05315983 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.02470024 |
| 102 | MP0004145_abnormal_muscle_electrophysio | 1.00908844 |
| 103 | MP0004885_abnormal_endolymph | 1.00727533 |
| 104 | MP0008872_abnormal_physiological_respon | 1.00457626 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 1.00366782 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.98818474 |
| 107 | MP0002933_joint_inflammation | 0.98545513 |
| 108 | MP0005365_abnormal_bile_salt | 0.97410340 |
| 109 | MP0009379_abnormal_foot_pigmentation | 0.97347492 |
| 110 | MP0001853_heart_inflammation | 0.96919411 |
| 111 | MP0002398_abnormal_bone_marrow | 0.96351810 |
| 112 | MP0002429_abnormal_blood_cell | 0.95363811 |
| 113 | MP0004947_skin_inflammation | 0.94588099 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.93617017 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.93409927 |
| 116 | MP0003866_abnormal_defecation | 0.91512299 |
| 117 | MP0001545_abnormal_hematopoietic_system | 0.90848135 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.90848135 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.90741014 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90249067 |
| 121 | MP0005310_abnormal_salivary_gland | 0.89909110 |
| 122 | MP0003690_abnormal_glial_cell | 0.89099704 |
| 123 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88450789 |
| 124 | MP0009840_abnormal_foam_cell | 0.87243773 |
| 125 | MP0003122_maternal_imprinting | 0.86592906 |
| 126 | MP0000778_abnormal_nervous_system | 0.86005198 |
| 127 | MP0004142_abnormal_muscle_tone | 0.85568756 |
| 128 | MP0003279_aneurysm | 0.85472370 |
| 129 | MP0005075_abnormal_melanosome_morpholog | 0.85410672 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.85148912 |
| 131 | MP0004085_abnormal_heartbeat | 0.84745201 |
| 132 | MP0000747_muscle_weakness | 0.84365786 |
| 133 | MP0000750_abnormal_muscle_regeneration | 0.82944352 |
| 134 | MP0002405_respiratory_system_inflammati | 0.82289194 |
| 135 | MP0005257_abnormal_intraocular_pressure | 0.81993143 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.81829913 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.81271248 |
| 138 | MP0005390_skeleton_phenotype | 0.80673995 |
| 139 | MP0002722_abnormal_immune_system | 0.79422565 |
| 140 | MP0005166_decreased_susceptibility_to | 0.79261592 |
| 141 | MP0004233_abnormal_muscle_weight | 0.79217515 |
| 142 | MP0002254_reproductive_system_inflammat | 0.78947578 |
| 143 | MP0002229_neurodegeneration | 0.78847036 |
| 144 | MP0001542_abnormal_bone_strength | 0.77391420 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.77010902 |
| 146 | MP0005332_abnormal_amino_acid | 0.76467506 |
| 147 | MP0002152_abnormal_brain_morphology | 0.75896745 |
| 148 | MP0000689_abnormal_spleen_morphology | 0.75778691 |
| 149 | MP0010234_abnormal_vibrissa_follicle | 0.75316623 |
| 150 | MP0003634_abnormal_glial_cell | 0.73250143 |
| 151 | MP0000678_abnormal_parathyroid_gland | 0.72717542 |
| 152 | MP0001529_abnormal_vocalization | 0.71556801 |
| 153 | MP0001663_abnormal_digestive_system | 0.71375467 |
| 154 | MP0000703_abnormal_thymus_morphology | 0.71362800 |
| 155 | MP0002970_abnormal_white_adipose | 0.71315040 |
| 156 | MP0002998_abnormal_bone_remodeling | 0.71301497 |
| 157 | MP0003786_premature_aging | 0.69367227 |
| 158 | MP0005499_abnormal_olfactory_system | 0.68884888 |
| 159 | MP0005394_taste/olfaction_phenotype | 0.68884888 |
| 160 | MP0001984_abnormal_olfaction | 0.68018326 |
| 161 | MP0002090_abnormal_vision | 0.67690611 |
| 162 | MP0005646_abnormal_pituitary_gland | 0.66967708 |
| 163 | MP0001765_abnormal_ion_homeostasis | 0.64227198 |
| 164 | MP0010386_abnormal_urinary_bladder | 0.62876050 |
| 165 | MP0006035_abnormal_mitochondrial_morpho | 0.62606992 |
| 166 | MP0000749_muscle_degeneration | 0.61336847 |
| 167 | MP0006036_abnormal_mitochondrial_physio | 0.61046699 |
| 168 | MP0001664_abnormal_digestion | 0.60012276 |
| 169 | MP0003183_abnormal_peptide_metabolism | 0.59663557 |
| 170 | MP0004036_abnormal_muscle_relaxation | 0.59584499 |
| 171 | MP0004215_abnormal_myocardial_fiber | 0.59483188 |
| 172 | MP0003252_abnormal_bile_duct | 0.59351647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.36652985 |
| 2 | Focal motor seizures (HP:0011153) | 4.87539833 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.63565734 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.63565734 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.63565734 |
| 6 | Visual hallucinations (HP:0002367) | 4.57135140 |
| 7 | Focal seizures (HP:0007359) | 4.26886872 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.77903756 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.73051753 |
| 10 | Action tremor (HP:0002345) | 3.61007951 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.38965877 |
| 12 | Absence seizures (HP:0002121) | 3.34824749 |
| 13 | Atonic seizures (HP:0010819) | 3.33359681 |
| 14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.29025722 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.29025722 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.29025722 |
| 17 | Prolonged neonatal jaundice (HP:0006579) | 3.26561800 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.24537237 |
| 19 | Depression (HP:0000716) | 3.23851272 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 3.20906247 |
| 21 | Vertebral compression fractures (HP:0002953) | 3.19069832 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.14026521 |
| 23 | Ventricular fibrillation (HP:0001663) | 3.10615642 |
| 24 | Loss of speech (HP:0002371) | 3.09150520 |
| 25 | Ankle clonus (HP:0011448) | 3.08917856 |
| 26 | Papilledema (HP:0001085) | 3.08449210 |
| 27 | J-shaped sella turcica (HP:0002680) | 3.06784909 |
| 28 | Febrile seizures (HP:0002373) | 2.93156541 |
| 29 | Epileptic encephalopathy (HP:0200134) | 2.91742046 |
| 30 | Bundle branch block (HP:0011710) | 2.90402628 |
| 31 | Abnormal social behavior (HP:0012433) | 2.90078009 |
| 32 | Impaired social interactions (HP:0000735) | 2.90078009 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 2.86018739 |
| 34 | Dialeptic seizures (HP:0011146) | 2.83098271 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.81654497 |
| 36 | Poor eye contact (HP:0000817) | 2.80297872 |
| 37 | Hypokinesia (HP:0002375) | 2.75545463 |
| 38 | Torticollis (HP:0000473) | 2.72184066 |
| 39 | Anxiety (HP:0000739) | 2.70162547 |
| 40 | Postural instability (HP:0002172) | 2.67077456 |
| 41 | Pheochromocytoma (HP:0002666) | 2.67041058 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.66823519 |
| 43 | Focal dystonia (HP:0004373) | 2.66064561 |
| 44 | Hypercortisolism (HP:0001578) | 2.64927363 |
| 45 | Mutism (HP:0002300) | 2.60069209 |
| 46 | Cholecystitis (HP:0001082) | 2.57260917 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.57260917 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.57055352 |
| 49 | Hemiplegia (HP:0002301) | 2.56611162 |
| 50 | Status epilepticus (HP:0002133) | 2.56156723 |
| 51 | Cerebral inclusion bodies (HP:0100314) | 2.54240311 |
| 52 | Testicular atrophy (HP:0000029) | 2.54027834 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53369534 |
| 54 | Joint stiffness (HP:0001387) | 2.52494259 |
| 55 | Urinary urgency (HP:0000012) | 2.51873706 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50085778 |
| 57 | Craniofacial dystonia (HP:0012179) | 2.49583086 |
| 58 | Dysmetria (HP:0001310) | 2.48563082 |
| 59 | Dysdiadochokinesis (HP:0002075) | 2.47179860 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.46933321 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.45342674 |
| 62 | Insomnia (HP:0100785) | 2.42972979 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.42097652 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.42043331 |
| 65 | Annular pancreas (HP:0001734) | 2.33024096 |
| 66 | Mediastinal lymphadenopathy (HP:0100721) | 2.29391081 |
| 67 | Dysmetric saccades (HP:0000641) | 2.28007365 |
| 68 | Truncal ataxia (HP:0002078) | 2.27823957 |
| 69 | Rapidly progressive (HP:0003678) | 2.27524659 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.27308369 |
| 71 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.26952524 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.24308420 |
| 73 | Nuclear cataract (HP:0100018) | 2.23414924 |
| 74 | Intention tremor (HP:0002080) | 2.22817577 |
| 75 | Hyperacusis (HP:0010780) | 2.20735110 |
| 76 | Stridor (HP:0010307) | 2.20625276 |
| 77 | Megalencephaly (HP:0001355) | 2.20347990 |
| 78 | Failure to thrive in infancy (HP:0001531) | 2.19144201 |
| 79 | Ocular albinism (HP:0001107) | 2.18976821 |
| 80 | Bradykinesia (HP:0002067) | 2.18891399 |
| 81 | Gout (HP:0001997) | 2.17804899 |
| 82 | Increased IgM level (HP:0003496) | 2.16451590 |
| 83 | Obstructive lung disease (HP:0006536) | 2.15649890 |
| 84 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15649890 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.13729807 |
| 86 | Axonal loss (HP:0003447) | 2.13410083 |
| 87 | Neuronal loss in central nervous system (HP:0002529) | 2.12863671 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.11336581 |
| 89 | Distal upper limb amyotrophy (HP:0007149) | 2.11336581 |
| 90 | Amyloidosis (HP:0011034) | 2.10309329 |
| 91 | Scanning speech (HP:0002168) | 2.05147489 |
| 92 | Myotonia (HP:0002486) | 2.03112998 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02826672 |
| 94 | Tetraplegia (HP:0002445) | 2.02541665 |
| 95 | Cervical subluxation (HP:0003308) | 2.01063635 |
| 96 | Hyperparathyroidism (HP:0000843) | 2.00798491 |
| 97 | Resting tremor (HP:0002322) | 2.00134820 |
| 98 | Spastic paraparesis (HP:0002313) | 1.99779754 |
| 99 | Athetosis (HP:0002305) | 1.99655168 |
| 100 | Deep venous thrombosis (HP:0002625) | 1.99622245 |
| 101 | Increased serum ferritin (HP:0003281) | 1.99049665 |
| 102 | Cerebral aneurysm (HP:0004944) | 1.98709041 |
| 103 | Agitation (HP:0000713) | 1.98453859 |
| 104 | Hand muscle atrophy (HP:0009130) | 1.98289133 |
| 105 | Postural tremor (HP:0002174) | 1.97690826 |
| 106 | Spastic gait (HP:0002064) | 1.96929652 |
| 107 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.96926956 |
| 108 | Cholelithiasis (HP:0001081) | 1.96464444 |
| 109 | Exercise-induced myalgia (HP:0003738) | 1.95924198 |
| 110 | Hepatocellular necrosis (HP:0001404) | 1.95196729 |
| 111 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94964319 |
| 112 | Rigidity (HP:0002063) | 1.94895050 |
| 113 | Hypertensive crisis (HP:0100735) | 1.94548772 |
| 114 | Neonatal onset (HP:0003623) | 1.94366209 |
| 115 | Impaired smooth pursuit (HP:0007772) | 1.93891347 |
| 116 | Progressive microcephaly (HP:0000253) | 1.93777302 |
| 117 | Increased muscle lipid content (HP:0009058) | 1.93289966 |
| 118 | Impaired vibratory sensation (HP:0002495) | 1.92070417 |
| 119 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91928228 |
| 120 | Abnormal number of erythroid precursors (HP:0012131) | 1.91734651 |
| 121 | Akinesia (HP:0002304) | 1.91283143 |
| 122 | Pointed chin (HP:0000307) | 1.89975328 |
| 123 | Growth hormone excess (HP:0000845) | 1.89942620 |
| 124 | Global brain atrophy (HP:0002283) | 1.89875457 |
| 125 | Lower limb asymmetry (HP:0100559) | 1.89517182 |
| 126 | Progressive inability to walk (HP:0002505) | 1.88695723 |
| 127 | Paraparesis (HP:0002385) | 1.87812456 |
| 128 | Apathy (HP:0000741) | 1.86271453 |
| 129 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.86061227 |
| 130 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.86061227 |
| 131 | Impaired pain sensation (HP:0007328) | 1.84785776 |
| 132 | Abnormality of pain sensation (HP:0010832) | 1.84785776 |
| 133 | Hypoventilation (HP:0002791) | 1.83777281 |
| 134 | Genetic anticipation (HP:0003743) | 1.83774608 |
| 135 | Iris hypopigmentation (HP:0007730) | 1.83553485 |
| 136 | Abnormal EKG (HP:0003115) | 1.83080263 |
| 137 | Hyperthyroidism (HP:0000836) | 1.82741001 |
| 138 | Emotional lability (HP:0000712) | 1.82628849 |
| 139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.82627625 |
| 140 | Sudden death (HP:0001699) | 1.81966637 |
| 141 | Petechiae (HP:0000967) | 1.81943167 |
| 142 | Peripheral hypomyelination (HP:0007182) | 1.81825294 |
| 143 | Clonus (HP:0002169) | 1.81490129 |
| 144 | Obstructive sleep apnea (HP:0002870) | 1.80271613 |
| 145 | Cellulitis (HP:0100658) | 1.80196506 |
| 146 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79059780 |
| 147 | Abnormal gallbladder morphology (HP:0012437) | 1.78783338 |
| 148 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78063154 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.78054447 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78054447 |
| 151 | Hemiparesis (HP:0001269) | 1.77982595 |
| 152 | Delusions (HP:0000746) | 1.77755214 |
| 153 | Hypsarrhythmia (HP:0002521) | 1.77649845 |
| 154 | Diplopia (HP:0000651) | 1.76495848 |
| 155 | Abnormality of binocular vision (HP:0011514) | 1.76495848 |
| 156 | Ragged-red muscle fibers (HP:0003200) | 1.76151824 |
| 157 | Epileptiform EEG discharges (HP:0011182) | 1.75503645 |
| 158 | Heart block (HP:0012722) | 1.74390099 |
| 159 | Dementia (HP:0000726) | 1.74090449 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.72974023 |
| 161 | Spinal canal stenosis (HP:0003416) | 1.72865352 |
| 162 | Mesangial abnormality (HP:0001966) | 1.72229164 |
| 163 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.72200962 |
| 164 | Stomatitis (HP:0010280) | 1.70064291 |
| 165 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69718090 |
| 166 | Retinal atrophy (HP:0001105) | 1.67900573 |
| 167 | Dysautonomia (HP:0002459) | 1.67543179 |
| 168 | Diminished motivation (HP:0000745) | 1.66346726 |
| 169 | Myopathic facies (HP:0002058) | 1.65067987 |
| 170 | Flattened epiphyses (HP:0003071) | 1.65065222 |
| 171 | Myositis (HP:0100614) | 1.64555900 |
| 172 | Opisthotonus (HP:0002179) | 1.64519920 |
| 173 | Diminished movement (HP:0002374) | 1.63720885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.06662668 |
| 2 | TESK2 | 3.50941404 |
| 3 | NTRK3 | 3.45885983 |
| 4 | NME2 | 3.45332347 |
| 5 | DAPK2 | 2.97107768 |
| 6 | KSR2 | 2.91451688 |
| 7 | EPHA4 | 2.82626944 |
| 8 | TESK1 | 2.73506746 |
| 9 | PRKD3 | 2.67392631 |
| 10 | IRAK3 | 2.64758129 |
| 11 | MAP3K4 | 2.56862042 |
| 12 | SMG1 | 2.45971236 |
| 13 | MAP3K2 | 2.42424708 |
| 14 | MINK1 | 2.40761655 |
| 15 | NTRK1 | 2.38120273 |
| 16 | TRIB3 | 2.36421623 |
| 17 | MAP4K1 | 2.33805874 |
| 18 | PAK6 | 2.25692888 |
| 19 | MAP2K4 | 2.15415560 |
| 20 | PIM2 | 2.14257238 |
| 21 | VRK2 | 2.09548150 |
| 22 | SIK1 | 2.07717382 |
| 23 | CAMKK1 | 1.97365382 |
| 24 | MARK1 | 1.85876211 |
| 25 | MAP2K7 | 1.80674850 |
| 26 | TAOK2 | 1.79541746 |
| 27 | MAP2K3 | 1.70991581 |
| 28 | TBK1 | 1.65294572 |
| 29 | DAPK1 | 1.57534138 |
| 30 | ARAF | 1.56708856 |
| 31 | RIPK4 | 1.52096205 |
| 32 | MAP3K12 | 1.51421576 |
| 33 | GRK5 | 1.50898856 |
| 34 | STK38 | 1.47939573 |
| 35 | LMTK2 | 1.46059195 |
| 36 | PKN2 | 1.42633634 |
| 37 | TAOK1 | 1.36082043 |
| 38 | NTRK2 | 1.34739824 |
| 39 | RET | 1.33773788 |
| 40 | PRKCH | 1.31523967 |
| 41 | CDK5 | 1.30931106 |
| 42 | PHKG1 | 1.29371045 |
| 43 | PHKG2 | 1.29371045 |
| 44 | KSR1 | 1.27472244 |
| 45 | SIK2 | 1.27375977 |
| 46 | UHMK1 | 1.18995222 |
| 47 | LATS2 | 1.14481636 |
| 48 | SCYL2 | 1.14223103 |
| 49 | RIPK1 | 1.13937652 |
| 50 | TYRO3 | 1.12406284 |
| 51 | BRAF | 1.11450565 |
| 52 | ALK | 1.11414564 |
| 53 | MAP3K1 | 1.10182749 |
| 54 | SIK3 | 1.06046324 |
| 55 | KDR | 1.05643713 |
| 56 | MAP3K13 | 1.05098291 |
| 57 | FES | 1.04517469 |
| 58 | ERN1 | 1.03765685 |
| 59 | PINK1 | 1.03435057 |
| 60 | STK11 | 1.02114991 |
| 61 | ABL2 | 1.01753067 |
| 62 | CDK19 | 1.01154512 |
| 63 | NEK1 | 1.01100238 |
| 64 | MAP2K6 | 1.00992138 |
| 65 | MAP3K3 | 0.99803200 |
| 66 | EPHA2 | 0.95855615 |
| 67 | DAPK3 | 0.95532006 |
| 68 | PRKCG | 0.91883021 |
| 69 | IRAK4 | 0.91212330 |
| 70 | RPS6KA2 | 0.91165600 |
| 71 | MAP3K7 | 0.91089092 |
| 72 | PTK2B | 0.88400550 |
| 73 | MAP2K2 | 0.87359381 |
| 74 | ZAP70 | 0.84866334 |
| 75 | PDPK1 | 0.79097037 |
| 76 | TYK2 | 0.76928583 |
| 77 | CAMK1 | 0.76837088 |
| 78 | PAK3 | 0.76021495 |
| 79 | CDK15 | 0.75218702 |
| 80 | SGK3 | 0.74254680 |
| 81 | CDK14 | 0.73543690 |
| 82 | CDK18 | 0.72806688 |
| 83 | PDK1 | 0.72435494 |
| 84 | EEF2K | 0.72210113 |
| 85 | HIPK2 | 0.72194022 |
| 86 | CAMKK2 | 0.71269785 |
| 87 | SGK223 | 0.70587105 |
| 88 | SGK494 | 0.70587105 |
| 89 | MAP2K1 | 0.70517845 |
| 90 | PRKCI | 0.69185846 |
| 91 | PRKCZ | 0.69180140 |
| 92 | BMX | 0.69179146 |
| 93 | PDGFRA | 0.68499790 |
| 94 | PAK4 | 0.68345168 |
| 95 | LRRK2 | 0.67295459 |
| 96 | MAPK11 | 0.66607283 |
| 97 | PLK2 | 0.65541947 |
| 98 | CDK11A | 0.64490215 |
| 99 | IKBKB | 0.62923530 |
| 100 | DYRK1B | 0.61662720 |
| 101 | CDC42BPA | 0.59266416 |
| 102 | ILK | 0.58556205 |
| 103 | MAPK13 | 0.57119409 |
| 104 | MAPKAPK3 | 0.57013058 |
| 105 | RAF1 | 0.56684854 |
| 106 | TNK2 | 0.56042633 |
| 107 | BCKDK | 0.53588765 |
| 108 | MARK2 | 0.53441111 |
| 109 | EPHB1 | 0.52458030 |
| 110 | CAMK2A | 0.52442699 |
| 111 | MAPK12 | 0.52215235 |
| 112 | RPS6KC1 | 0.50491449 |
| 113 | RPS6KL1 | 0.50491449 |
| 114 | JAK2 | 0.50112404 |
| 115 | GRK6 | 0.49723851 |
| 116 | DDR2 | 0.49722803 |
| 117 | AURKA | 0.49255874 |
| 118 | MAP3K11 | 0.48911610 |
| 119 | CAMK4 | 0.48706579 |
| 120 | CSNK1G3 | 0.46679167 |
| 121 | NME1 | 0.46675841 |
| 122 | PRKD2 | 0.46508554 |
| 123 | SGK1 | 0.46384265 |
| 124 | CSF1R | 0.46277299 |
| 125 | RPS6KA3 | 0.45163294 |
| 126 | MAP3K10 | 0.44923053 |
| 127 | MOS | 0.44835262 |
| 128 | RPS6KA6 | 0.43361466 |
| 129 | IKBKE | 0.41992545 |
| 130 | PTK2 | 0.41923473 |
| 131 | TGFBR2 | 0.41388922 |
| 132 | FER | 0.40488314 |
| 133 | WNK4 | 0.39477821 |
| 134 | PTK6 | 0.38982696 |
| 135 | CAMK2G | 0.38929949 |
| 136 | PAK1 | 0.38777854 |
| 137 | BRSK1 | 0.38484165 |
| 138 | MAP3K14 | 0.38333288 |
| 139 | PRPF4B | 0.38201242 |
| 140 | FYN | 0.38150664 |
| 141 | FGR | 0.36999445 |
| 142 | ICK | 0.35806512 |
| 143 | STK16 | 0.35515303 |
| 144 | LIMK1 | 0.34325529 |
| 145 | WNK1 | 0.33912237 |
| 146 | MAPKAPK2 | 0.31092795 |
| 147 | TLK1 | 0.30716112 |
| 148 | BTK | 0.28633271 |
| 149 | MAPK4 | 0.27249950 |
| 150 | MAP3K8 | 0.27210174 |
| 151 | SYK | 0.27196608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.77117339 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.81442967 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.13650349 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 3.03806172 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.81606176 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.64341086 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47732701 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41584662 |
| 9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 2.19863422 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.19554127 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.17469605 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.16461325 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.14269982 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09605042 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 2.09179845 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.98554153 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.96014681 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.91196740 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.86180213 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.82097184 |
| 21 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80414284 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.78972356 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.77269046 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.75429184 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.72643380 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.69720926 |
| 27 | Salivary secretion_Homo sapiens_hsa04970 | 1.69675098 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.63452138 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.63227300 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61135734 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56177234 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53444964 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50865191 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.47316247 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.44903011 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42551357 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.42453490 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.41067305 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40635124 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39054623 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35766877 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28302185 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27591802 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.24975485 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24474890 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24376518 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21805659 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21056911 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.20223989 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18139680 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17858939 |
| 52 | Base excision repair_Homo sapiens_hsa03410 | 1.17506606 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.17386992 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15698320 |
| 55 | Glioma_Homo sapiens_hsa05214 | 1.15543982 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 1.15412259 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13447577 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12905500 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 1.11629553 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10943327 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10073957 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09481457 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09285423 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07616304 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 1.07218040 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06472435 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 1.04856155 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02859608 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.02226282 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 1.02189479 |
| 71 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02012056 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01241226 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00306869 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00267095 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99144498 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94157916 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92652800 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.90656018 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89863522 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.87252420 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86358405 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.85881186 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85761514 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84986445 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84199731 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83074417 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.82750033 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82041915 |
| 89 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81183502 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.79143112 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78957117 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78639436 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78119853 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78052043 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77509960 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.77466198 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77274471 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77160567 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77059887 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76321181 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76205320 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76121648 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75252650 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73970797 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73178195 |
| 106 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71862907 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71461288 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71365527 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70555850 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68978805 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68174704 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.67297578 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66715653 |
| 114 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66667332 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.64570663 |
| 116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64153361 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63345162 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63148331 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62580183 |
| 120 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61819606 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60911089 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60817164 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59692141 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59500264 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59446408 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57903585 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.55850193 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55499941 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55363836 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55128991 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52724645 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.51958224 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50799970 |
| 134 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49767987 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.48570244 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48394698 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.47499040 |
| 138 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47432525 |
| 139 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47010631 |
| 140 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.46815891 |
| 141 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45239920 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44602254 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44178867 |
| 144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44155297 |
| 145 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43572079 |
| 146 | Asthma_Homo sapiens_hsa05310 | 0.43482044 |
| 147 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43237275 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.42110507 |
| 149 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41987104 |
| 150 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40695617 |
| 151 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40340894 |
| 152 | Influenza A_Homo sapiens_hsa05164 | 0.38950551 |
| 153 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38001142 |
| 154 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.37835581 |
| 155 | DNA replication_Homo sapiens_hsa03030 | 0.37805876 |
| 156 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37706144 |
| 157 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36024937 |
| 158 | Axon guidance_Homo sapiens_hsa04360 | 0.35792819 |
| 159 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35626309 |
| 160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34802847 |
| 161 | Proteasome_Homo sapiens_hsa03050 | 0.34751796 |
| 162 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34338328 |
| 163 | Measles_Homo sapiens_hsa05162 | 0.34204306 |
| 164 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34049896 |
| 165 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33285339 |
| 166 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33227267 |
| 167 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33114839 |
| 168 | Bladder cancer_Homo sapiens_hsa05219 | 0.32792659 |
| 169 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32763596 |
| 170 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31904718 |
| 171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31674859 |
| 172 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31259043 |

